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Longinterspersedelements(LINE-1orL1)arethemostactivetransposableelementsinthehumangenome.Duetotheirhighcopy
numberandabilitytosponsorretrotranspositionofnonautonomousRNAsequences,uncheckedL1activitycannegativelyimpact
the genome by a number of means. Substantial evidence in lower eukaryotes demonstrates that the RNA interference (RNAi)
machinery plays a major role in containing transposon activity. Despite extensive analysis in other eukaryotes, no experimental
evidence has been presented that L1-derived siRNAs exist, or that the RNAi plays a signiﬁcant role in restricting L1 activity in the
human genome. This review will present evidence showing a direct role for RNAi in suppressing the movement of transposable
elements in other eukaryotes, as well as speculate on the role RNAi might play in protecting the human genome from LINE-1
activity.
Copyright © 2006 Harris S. Soifer. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
IMPORTANCE OF LIMITING L1 RETROTRANSPOSITION
IN THE HUMAN GENOME
The majority of the human genome is comprised of DNA
from repetitive sequences and mobile genetic elements.
Retrotransposons,mobileDNAthatmovesviaanRNAinter-
mediate, are the most abundant transposable elements and
comprise approximately 40% of human genomic sequence.
Of these retrotransposons, the non-long terminal repeat
(non-LTR) long interspersed elements (LINE-1 or L1) retain
a degree of autonomy, as some full-length (FL) L1s encode
functional proteins necessary for retrotransposition [1]. Al-
thoughover99%ofL1sequencesareinactive,eitherthrough
deleterious mutations, 5 -end truncations, or internal re-
arrangements, bioinformatic and empirical analysis predict
that 100 FL-L1s have the capacity for autonomous move-
ment,andthusaretermedretrotransposition-competentL1s
(RC-L1s) [2]. The consensus RC-L1 is 6kb and contains a
5  untranslated region (5  UTR) with an internal promoter,
twononoverlappingopenreadingframes(ORF1andORF2),
and a 3  UTR with its own polyadenylation signal. ORF1
encodes a 40kd (p40) RNA binding protein that forms ri-
bonucleoprotein particles with L1 RNA [3]. ORF2 encodes a
150kd protein with an N-terminal endonuclease (EN) and a
C-terminal reverse transcriptase (RT) domain [1].
Despite their small number, the 100 or so remaining RC-
L1s continue to threaten the human genome. Recently, 82
FL-L1s with intact ORFswerecloned and their activity tested
using a cell culture retrotransposition assay. Almost one-half
(40/82) of the FL-L1s were shown to be retrotransposition
competent, with a majority of the retrotransposition activ-
ity contributed by six “hot” L1s [2]. Although the poten-
tial for active L1s to greatly increase their copy number is
limited by the propensity for truncations to occur at the
5  end during integration, two highly active RC-L1s (L1RP
and L1b-Thal) have been characterized that are the result of
disease-causing, full-length de novo integration events [4].
SubsequentcomparisonwithotherRC-L1sshowedthatboth
L1RP and L1b-Thal exhibit high activity in cell culture and be-
longtoagroupof“hot”L1sresponsibleformostoftheretro-
transposition that occurs in our genome today [2]. In addi-
tion, characterization of cloned retrotransposition events us-
ing tagged-RC-L1 constructs in cultured cancer cells indicate
that ∼10% of L1 insertions are accompanied by large chro-
mosomal rearrangements, suggesting that active L1s could
also lead to genomic instability [5, 6]. Furthermore, an in-
creasing number of reports using advanced molecular tech-
niques illustrate that L1s continue to negatively impact the
ﬁtness of the genome, either through de novo retrotranspo-
sition resulting in insertional mutagnesis, or as the result of
unequal recombination between dispersed L1s and gene se-
quences [7–10].
Undoubtedly, both positive and negative factors con-
tinue to regulate L1 activity. For example, experiments us-
ing tagged retrotransposition-incompetent constructs (ie,
Alu, pseudogene, and mutant L1s) demonstrate that nonau-
tonomous RNAs are mobilized in trans by the L1 machin-
ery at a much lower frequency compared to the RC-L1 that2 Journal of Biomedicine and Biotechnology
encoded them [11, 12]. This characteristic, known as cis-
preference, limits the ability of nonautonomous retrotrans-
posons to form functional RNPs, thereby preventing the ac-
cumulationofdead-endintermediates.Infact,cis-preference
helps ensure the survival of the small number of RC-L1s that
would otherwise compete with nonautonomous retrotrans-
posons for limited host factors. The idea that RC-L1 might
be under purifying selection, as well as various ways that L1s
cannegativelyimpactthegenome,arguesinfavorofmultiple
mechanismstoregulateL1activity.Considerableexperimen-
tal evidence exists that RNA interference (RNAi) represses
the activity of many diﬀerent transposable elements in other
eukaryotes, leading to speculation that RNAi might act in a
similar manner against human L1s.
RNAi is a conserved eukaryotic mechanism in which
double-stranded RNA (dsRNA) recognizes homologous
mRNA transcripts and causes sequence-speciﬁc inhibition of
geneexpressionthroughanumberofmechanisms(Figure 1)
[13]. RNAi is initiated by cleavage of endogenous long
dsRNA or short-hairpin RNA (shRNA or pre-miRNA) pre-
cursors by the RNase III enzyme Dicer into 21–25 nucleotide
small interfering RNA (siRNA) or microRNA (miRNA)
eﬀector molecules [14, 15]. The siRNAs, which are per-
fectly complementary to their target, recognize their cog-
nate mRNA and become associated with a large multi-
protein complex referred to as the RNA-induced silencing
complex (RISC) that destroys target mRNAs by endonucle-
olytic cleavage at regions homologous to the siRNA [16, 17]
(Figure 1(a)). miRNAs, on the other hand, are imperfectly
matched with their target sequences and associate with ho-
mologous mRNAs in a ribonucleoprotein complex resulting
in sequence-speciﬁc reduction of gene expression through
translation inhibition [13, 18]( Figure 1(b)). In addition to
gene silencing at the posttranscriptional level (ie, siRNA-
mediated degradation or miRNA-mediated translation inhi-
bition), siRNAs targeting promoter regions in genomic DNA
can bring about DNA and histone methylation, resulting in
promoter shutdown in a process termed transcriptional gene
silencing (TGS) (Figure 1(c))[ 13].
RNAi SUPPRESSES TRANSPOSABLE ELEMENTS IN
MANY OF EUKARYOTES
ThegeneticlinkbetweenRNAiandcontrolofmobilegenetic
elements was initially established following EMS mutagene-
sis screens of Caenorhabditis elegans.S e v e r a lCe l e g a n smu-
tants deﬁcient in RNAi also show increased activity of DNA
transposons, speciﬁcally Tc1, Tc3, and Tc5, as demonstrated
by Southern blot analysis for Tc-directed insertions (Table 1)
[19, 20]. Further screens in Ce l e g a n sdemonstrated that
while not all genes necessary to RNAi are also required for
transposon silencing, there is substantial cross-talk between
the two regulatory pathways [21]. Additional evidence sup-
porting a role for RNAi in silencing both transposons and
retrotransposons has been demonstrated through genetic
analysis in a number of other eukaryotes. One problem has
been translating the results obtained in these model eukary-
otes to the more complex human genome. Fortunately, the
rich bioinformatics resources spawned from the genome se-
quencingeﬀortsoverthelastdecadepermittheidentiﬁcation
of human orthologs of essential RNAi components.
Human cells encode one Dicer (DCR) protein, an en-
zyme with two RNase III domains that forms an intramolec-
ular dimer to cleave dsRNA in a processive manner pro-
ducing 21–25 nucleotide siRNAs [22]. The early embryonic
lethality observed in mice with the Dicer null genotype
(Dcr-1 −/−) conﬁrms an essential role for Dicer in mam-
malian development. Unfortunately, the establishment of
mouse embryonic ﬁbroblast lines for further study has been
hampered by the early death (E7.5) of Dicer null embryos
[23]. To provide a more favorable system to study the role
of Dicer in controlling mammalian retroelements, Dicer-
deﬁcient mouse embryonic stem (ES) cells were developed.
Increased transcription of murine L1 elements was observed
in the absence of Dicer, but not wild-type ES cells, providing
the ﬁrst direct evidence that RNAi controls the expression
of murine L1 retrotransposons [24]. The observed increase
in L1 expression was measured by quantitative RT-PCR us-
ing primers homologous to the murine L1 5  UTR, presum-
ably allowing quantiﬁcation of transcripts originating from
the ∼ 3000 RC-L1s that inhabit the C57/BL6 genome. In
addition, transcripts from intracisternal A particles (IAPs),
an active murine LTR-retrotransposon, were also elevated in
the absence of Dicer. This report supports earlier work in
which IAP and murine endogenous retrovirus-L transcripts
were up-regulated following injection of anti-Dicer dsRNA
into 2- and 8-cell stage mouse embryos [25]. As Dicer ac-
tivity is necessary for limiting transcription of both non-
LTR as well as LTR containing retrotransposons, one is not
reaching to propose Dicer-mediated cleavage of endogenous
retrotransposon-deriveddsRNAintosiRNAfunctionsinhu-
man cells.
The siRNA produced by Dicer is handed oﬀ to the RNA-
induced silencing complex (RISC). While the exact com-
ponents of Homo sapiens RISC remain to be completely
characterized, siRNA-mediated knockdown of in HeLa cells,
as well as gene targeting experiments in mice, demon-
strate that the RISC-component AGO2 is essential for tar-
g e tm R N Ac l e a v a g e( Figure 1(a))[ 26, 27]. Selective inacti-
vation of AGO2 orthologs in lower eukaryotes demonstrates
that RISC-associated Ago proteins are required for silencing
both DNA transposons and retrotransposons. For example,
loss of the AGO2 ortholog qde-2 in Neurospora crassa leads
to increased expression of the LINE-like retrotransposon,
Tad. Moreover, deletion of both Dicer genes causes an in-
crease in Tad activity, linking the initiation step in RNAi
to non-LTR retrotransposon silencing [28]. An interesting
aspect of the analysis of Tad retrotransposition is that the
Neurospora genome, which is devoid of active transposons
through the action of eﬃcient homology-dependent gene si-
lencing mechanisms such as repeat-induced point mutations
(RIP), requires an intact RNAi response to respond to the in-
troductionbytransformationofanactiveTadelement.Thus,
perhaps one role of RNAi in higher eukaryotes is to permit a
rapid and potent response to the sudden activation of retro-
transposons.Harris S. Soifer 3
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Figure 1: RNAi-based gene silencing pathways in H sapiens. (a) Dicer cleaves long double-stranded RNA (dsRNA) or short-hairpin RNA
(shRNA) into functional siRNA with characteristic 3  overhangs. siRNAs are incorporated into RISC, recognize the target mRNA through
an unknown subunit(s), and cleavage is performed by AGO2. (b) Precursor microRNAs (pre-miRNA), which themselves are a cleavage
product of a primary microRNA transcript, are further processed by Dicer into functional miRNAs that associate with AGO2 into a miRNA
ribonucleoprotein (miRNP). miRNPs recognize their target mRNAs resulting in translation inhibition by an undeﬁned mechanism. (c)
Transcriptional gene silencing is initiated by Dicer-mediated cleavage of long dsRNA (eg, centromere dsRNA) into siRNA that associate with
the RITS complex. Putative components of H sapiens RITS are depicted: AGO-argonaute; DNMT-DNA methyltransferase; HDAC-histone
deacetylase; HP1-heterochromatin protein 1.
In addition to LINE-like Tad retrotransposons, increased
transcript levels of the Ingi and SLACS retroposon elements
are observed in cells lacking Ago1, the AGO2 ortholog of
Trypanosoma brucei RISC [29]. Several other spontaneous
or induced AGO mutants, such as the Arabidopsis Ago4 and
Drosophila piwi mutants, also show elevated levels of retro-
transposons [30–33]. Thus, genetic evidence from a variety
of organisms links both the initiation step (Dicer) and RISC-
mediated eﬀector step (AGO) of RNAi to the control mobile
genetic elements. Moreover, the fact that diﬀerent classes of
transposableelements(DNAtransposons,LTRandnon-LTR
retrotransposons, and endogenous retrovirus sequences) are
up-regulated in the absence of the RNAi machinery supports
the generalization that RNAi is part of the eukaryotic innate
immune system to protect the genome from the mutational
load of parasitic sequences [34]( Table 1).
DOES RNAi CONTROL LINE-1 ACTIVITY IN
HUMAN CELLS?
So far, there is no direct evidence that the RNAi pathway in
human cells protects the genome from the activity of L1s.
Direct genetic evidence has been hard to come by in hu-
man cells because of the diﬃculty in inhibiting RNAi gene
function. For other model eukaryotes such as Ce l e g a n sand
Schizosaccharomyces pombe, the high rate of homologous re-
combination (HR) and ability to perform large-scale genetic
screens, permits the study of mutant phenotypes through
insertion and/or inactivation of speciﬁc genes [35]. More-
over, the recent application of RNAi technology to selectively
inhibit gene function in mammalian cells both in culture
and in vivo had made it less necessary to rigorously pursue
methods that enhance the eﬃciency of HR in mammalian4 Journal of Biomedicine and Biotechnology
Table 1:EukaryoticRNAiorthologsinvolvedinsilencingtransposableelements.Hsapiensorthologs,ifpresentintheHomologenedatabase,
are indicated. N.D. implies not determined.
Organism
RNAi genes
implicated in
silencing TEs
Human
ortholog
Transposable
element
silenced
siRNAs
detected? Reference(s)
Caenorhabditis elegans
mut-7 —
Tc1, Tc3, Tc5 DNA
transposons
Terminal inverted
repeat (TIR) of Tc1 [19–21, 48] rde-2 AGO2
mut-16 —
mut-14 —
Drosophila melanogaster piwi PIWI
Gypsy ERV 5  UTR
[32, 33] Copia retrotransposon N.D.
Mdg1 retrotransposon N.D.
Trypanosma bruceii Ago1 AGO2 Ingi retroposon ORF 1 [29, 30]
SLACS retrotransposon ORF 1 and 3  UTR
Neurosporra crassa qde-2 AGO2 Tad retrotransposon ORF 1 and ORF 2 [28]
dcl1/dcl2 DICER1
Mus musculus Dicer-1 DICER-1 LINE-1 N.D. [24, 25]
Intracisternal A particle N.D.
Arabidopsis thaliana Ago4 — AtSN1 retroelement AtSN1∗ [31]
∗AtSN1 siRNA was determined by Northern blot with a full-length 159 nucleotides sense AtSN1 RNA probe.
cells. Although several genetic screens in mammalian cells
have been conducted using shRNA libraries, one can appre-
ciatethisRNAi-mediatedapproachwouldbeproblematicfor
studying the role that RNAi plays in controlling human L1s
[36, 37]. It is possible to achieve transient inhibition of the
RNAi pathway by transfecting human cells with large quan-
tities (>50nM) of siRNA targeting one of the RNAi compo-
nents (eg, DICER or AGO2) [15, 38]. However, functional
inhibition of the RNAi pathway is directly proportional to
transfection eﬃciency and varies between cell lines (unpub-
lishedobservations).Inaddition,somevirusproductsarein-
hibitors of RNAi, either by successfully competing with en-
dogenous dsRNA for Dicer, as is the case for the adenovirus
VA1 noncoding RNA, or by sequestering siRNA in an inac-
tive complex [39–41]. Although one group reported eﬃcient
down-regulationofDicerinHeLacellsusing a trans-cleaving
hammerhead ribozyme, only transient knockdown of Dicer
expression was achieved and they did not demonstrate func-
tional inhibition of the RNAi pathway [42].
In the absence of data showing increased L1 activity in
cells with an impaired RNAi pathway, the detection and
cloning of L1-derived siRNAs would support a role for RNAi
in controlling L1s. Eﬀorts to clone the small RNA fraction
from HeLa cells failed to ﬁnd microRNAs (miRNAs) pro-
duced from LINE-1, suggesting that if endogenous L1 miR-
NAs are produced, they are present at low levels or in spe-
ciﬁc cell types [43]. This initial cloning eﬀo r tr e l i e do nh i g h
throughput sequencing after annealing linker molecules to
the small RNA fraction puriﬁed from HeLa cells and might
overlook miRNAs from repetitive elements. Indeed, endoge-
nous siRNAs homologous to centromere repeats were not
cloned using this approach, despite being detected by RNase
protection and Northern blot analyses in chicken DT40 and
murine ES cells, respectively [24, 44]. Restriction of L1 siR-
NAsspeciﬁccelltypes,suchasprimordialgermtissueand/or
gametes, would explain why earlier characterization of en-
dogenous siRNAs in human cervical carcinoma cells failed to
detect L1 siRNAs. Since L1s that retrotranspose in gametes
insure passage of their genetic information to the next gen-
eration without impacting host ﬁtness through somatic mu-
tagenesis, the cell might combat this threat by producing L1
siRNA at a speciﬁc time during gametogenesis. Despite the
advantage for L1s to restrict their expression in germ cells,
immunohistochemical analysis detected L1 ORF translation
products (ORF1p and ORF2p) in adult and fetal testicu-
lar tissue, as well as Sertoli, Leydig, and vascular endothe-
lial cells [45, 46]. Furthermore, a single case of insertional
mutagenesis by L1 in somatic tissue has been reported [47].
Consequently, the threat posed by RC-L1s and functional
ORF proteins is not limited to the germline, and L1 siR-
NAs might also be present in somatic cells. Moreover, as the
amount of FL-L1 RNA in cultured somatic cells is relatively
low compared to L1 expression from established germ cell
tumors, somatic cells seem a ﬁtting place for posttranscrip-
tional degradation of FL-L1 RNA by siRNA to occur.
In lower eukaryotes where classical genetics has estab-
lished a direct link between RNAi and the control of mobile
genetic elements, siRNAs have been detected for both trans-
posons and retrotransposons. For example, siRNAs derived
from the LINE-like Tad retrotransposon were detected by
Northern blotting of totalRNA from Neurosporacrassaqde-2
mutants, but not wild-type progeny [28]( Table 1). qde-2 is
the AGO2 ortholog of N crassa RISC, and qde-2 mutants
are viable, but defective in RNAi. Tad-speciﬁc siRNAs wereHarris S. Soifer 5
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Figure 2: Proposed ways RNAi can control L1 activity. The consensus RC-L1 is depicted above. (a) L1 dsRNA produced from the 5  UTR
sense and antisense promoters is processed by Dicer and can target transcripts originating from RC-L1s for degradation. Alternatively, this
siRNA can also initiate histone and DNA methylation resulting in silencing of the L1s promoter. (b) Regions of L1 mRNA that form stable
hairpins through intramolecular base pairing could be Dicer substrates. The resulting siRNA is capable of a number of responses. (c) L1
dsRNA produced by read-through transcription from opposing cellular promoters is converted into siRNA that can target RC-L1 or ORF
transcripts for degradation.
detected with probes homologous to the Tad ORF1 or ORF2,
indicating that siRNAs wereproducedalong the lengthof the
element. In Ce l e g a n s , RNase protection analysis successfully
detected Tc1 dsRNA produced by read-through transcrip-
tion of endogenous promoters, as well as Tc1 siRNA in the
germ line of wild-type and RNAi-deﬁcient worms (Table 1).
In contrast to Tad siRNAs, endogenous siRNAs from the C
elegans DNA transposons were not derived from the trans-
posase ORF, but were detected with probes complementary
to the inverted repeats [48]. The fact that Ce l e g a n smuta-
tor strains also show increased mobility of other DNA trans-
posons such as Tc3 and Tc5, suggests that the Ce l e g a n s
RNAi is not speciﬁc to one element and RNAi might be a
general defense mechanism against transposon activity. En-
dogenous siRNAs homologous to retrotransposons have also
been detected by Northern blot in Arabidopsis thaliana and
Drosophila melanogaster (Table 1)[ 31, 32].
One requirement for the production of L1 siRNA would
be transcription of antisense L1 RNA that could hybridize
with L1 sense RNA to form dsRNA followed by Dicer-
mediated processing into siRNAs. An early study of L1 ex-
pression demonstrated that large quantities of both sense
and antisense L1 RNA of variable size greater than 1kb
are present in total RNA of a human teratocarcinoma cell
line, but not in the cytoplasmic RNA fractions where Dicer
processing of L1 dsRNA might occur [49]. The expression
proﬁle of L1 sequences is particularly complicated, not only
because the ∼ 3000 FL-L1s that reside in the human genome
contain an internal Pol II promoter that could remain tran-
scriptionally active, but strong cellular promoters nearby
presumably inactive L1s could result in the expression and
translation of unwanted L1 ORF products [50]( Figure 2(c)).
Therefore, the production of L1 dsRNA and its conversion
by Dicer into L1 siRNA might simply be a consequence of
the large number (>500000 copies/diploid genome) of L1
sequences and their proximity to transcriptionally active,
endogenous promoters (Figure 2(c)). The activity of adja-
cent promoters also establishes the possibility that L1 dsRNA
or siRNA could form through simple diﬀusion of comple-
mentary L1 transcripts expressed from distant loci. In addi-
tion to the activity of cellular promoters, regions of the L1
mRNA that form stable hairpin structures greater than 21
nucleotides might also be subject to Dicer processing into
siRNA (Figure 2(b)). To date, no L1 hairpin structures have
been deﬁned biochemically, although recombinant human
Dicer eﬃciently converts in vitro transcribed L1 dsRNA into
functional siRNA [51].
Instead of relying on adjacent promoters for transcrip-
tion, the production of sense/antisense L1 dsRNA might take
advantage of a unique feature of the L1 5  UTR; the existence6 Journal of Biomedicine and Biotechnology
ofaninternalpromoterthattranscribesL1senseRNAandan
antisense promoter (ASP) within nucleotides +400 to +600
(with respect to the 5 -end of the L1) of the 5  UTR that
transcribes minus-strand L1 sequence in the opposite direc-
tion (Figure 2(a)) [52, 53]. In cell lines where the 5  UTR
sense promoter shows transcriptional activity, the L1 ASP is
also active, albeit at lower levels [52, 54]. The resulting mi-
nus strand L1 RNA could anneal with plus strand L1 RNA
originating from the same L1 5  UTR region, or anneal with
another 5  UTR sense RNA by diﬀusion. Dicer could then
convert the dsRNA derived from the L1’s 5  UTR into siRNA.
It is important to recognize that 5  UTR siRNA can act on
transcripts arising from the L1s sense promoter as well as the
L1sASP(Figure 2(a)).Asthemechanismforchoosingwhich
strand of the siRNA (sense strand targeting antisense mes-
sage or antisense strand targeting sense message) is incorpo-
rated into RISC along with the target is not well understood,
it is possible that siRNA produced from this unique region of
the L1s 5  UTR could generate two diﬀerent RNAi responses
[55, 56]. First, L1 retrotransposition could be kept in check
by the antisense siRNA strand recognizing transcripts orig-
inating from RC-L1s. Additionally, the sense siRNA strand
could target transcripts from the L1s ASP, thereby regulat-
ing the expression of certain endogenous genes through the
action of a single pool of L1 5  UTR siRNAs [53].
As of yet, short duplex RNAs derived from L1s await
characterization, possibly owing to low-level expression in
speciﬁc cell types. Solution hybridization using radiolabelled
R N Ap r o b e sf r o mc o n s e rv e dr e gi o n so ft h eL 1 s5   UTR oﬀers
asensitive method todetect endogenous 5  UTR siRNAs.For
the detection of L1 siRNA, it will be necessary to distinguish
short, single-stranded L1 RNA that might hybridize to the
riboprobe and be mistakenly detected as L1 siRNA, from the
real L1 siRNA duplexes, which being double-stranded are re-
sistant to RNase A activity in the presence of high salt [48].
A further issue complicating the detection of L1 siRNAs by
ribonuclease digestion is the fact that single nucleotide mis-
matches between endogenous L1 siRNAs and the riboprobe
might cause cleavage and detection of protected fragments
that are smaller than the predicted 21–25 nucleotides size for
siRNA.Carefuldesignof5  UTRriboprobesshouldlimitpo-
tentialproblemscausedbysinglenucleotidemismatches.For
example, one could restrict detection of siRNAs to a speciﬁc
L1 subfamily, such as Ta-1d, which harbors a deletion at po-
sition 72 of the 5  UTR and distinguishes this youngest L1
subset from the slightly more divergent Ta-1nd [57].
CONCLUSION
There is ample experimental evidence, through genetic ma-
nipulation and biochemical analysis, that RNA interference
controls the activity of transposable elements in a variety
of eukaryotes such as A thaliana, S pombe, C elegans, and
Mm u s c u l u s[19–21, 24, 25, 28–33]. In addition, since the
RNAi response can eﬃciently limit retrotransposition of an
RC-L1 when introduced into transformed human cells, there
are no barriers per se to siRNA-mediated degradation of
L1s. The inability to uncover direct evidence that RNAi may
control L1 activity is not due to a lack of eﬀort, as several
groups are pursuing experiments to assess the interaction
b e t w e e nR N A ia n dh u m a nL 1 s .T h ed i ﬃculty in studying
the activity of endogenous human L1s in cells with an im-
paired RNAi pathway has slowed progress in showing a role
for RNAi in suppressing L1s. As current Dicer- and Ago2-
null mice show early embryonic lethality, the use of con-
ditional gene targeting through Cre-mediated excision of
ﬂoxed-RNAi alleles will permit further assessment for the
role of RNAi in L1 retrotransposition [23, 27]. Conditional
gene targeting and deletion of Dicer in the T cells causes loss
of microRNA processing linked to impaired T cell diﬀeren-
tiation [58]. These Dicer-deﬁcient T cells are viable, but lack
Dicer activity, thus providing a distinct Dicer-null popula-
tion for which retrotransposon activity can be assessed. It is
just a matter of time before proper experiments, combined
with dogged determination, provide direct evidence that hu-
man L1s are, to some degree, constrained by the RNAi path-
way.
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